Literature DB >> 16855273

Diastolic heart failure--a common and lethal condition by any name.

Gerard P Aurigemma.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16855273     DOI： 10.1056/NEJMe068128

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Diastology 2010: clinical approach to diastolic heart failure.

Authors:  Hirotsugu Yamada; Allan L Klein
Journal:  J Echocardiogr       Date:  2010-08-05

Review 2.  Systemic milieu and age-related deterioration.

Authors:  Hongxia Zhang; Ryan Cherian; Kunlin Jin
Journal:  Geroscience       Date:  2019-05-31       Impact factor: 7.713

3.  Risk factors and comorbidities in a community-wide sample of patients hospitalized with acute systolic or diastolic heart failure: the Worcester Heart Failure Study.

Authors:  Marcello Chinali; Samuel W Joffe; Gerard P Aurigemma; Raghavendra Makam; Theo E Meyer; Robert J Goldberg
Journal:  Coron Artery Dis       Date:  2010-05       Impact factor: 1.439

4.  Sex differences in the prevalence of diastolic dysfunction in cardiac surgical patients.

Authors:  Renata G Ferreira; Andrea Worthington; Chuan-Chin Huang; Sary F Aranki; Jochen D Muehlschlegel
Journal:  J Card Surg       Date:  2015-01-09       Impact factor: 1.620

Review 5.  What we know and do not know about sex and cardiac disease.

Authors:  John P Konhilas
Journal:  J Biomed Biotechnol       Date:  2010-04-22

Review 6.  Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction.

Authors:  Travis Bench; Daniel Burkhoff; John B O'Connell; Maria Rosa Costanzo; William T Abraham; Martin St John Sutton; Mathew S Maurer
Journal:  Curr Heart Fail Rep       Date:  2009-03

7.  Innate regeneration in the aging heart: healing from within.

Authors:  Piero Anversa; Annarosa Leri
Journal:  Mayo Clin Proc       Date:  2013-08       Impact factor: 7.616

8.  Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.

Authors:  Francesco S Loffredo; Matthew L Steinhauser; Steven M Jay; Joseph Gannon; James R Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall'Osso; Danika Khong; Jennifer L Shadrach; Christine M Miller; Britta S Singer; Alex Stewart; Nikolaos Psychogios; Robert E Gerszten; Adam J Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J Wagers; Richard T Lee
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

Review 9.  Tissue Doppler indices of diastolic function in critically ill patients and association with mortality - a systematic review.

Authors:  David Garry; Jim Newton; Claire Colebourn
Journal:  J Intensive Care Soc       Date:  2015-07-29

10.  A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction.

Authors:  Hari K Parthasarathy; Burkert Pieske; Marianne Weisskopf; Chris D Andrews; Patrick Brunel; Allan D Struthers; Thomas M MacDonald
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.